Loading…
Based on limited metadata, H.E.A.L. Marketplace received an FDA Warning Letter on May 12, 2023, for violations related to drug products. The letter identified three distinct violations, though specific details about the nature of these violations cannot be determined without access to the full warning letter text. The FDA's Drug Center issued this enforcement action, indicating the violations fall under federal drug regulations and manufacturing or marketing requirements.